News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Gallagher Brian M. Jr.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/24/2023 |
4
| Gallagher Brian M. Jr. (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns:
| Granted 50,938 options to buy
@ $0.4688, valued at
$23.9k
|
|
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/17/2021 |
4/A
| Gallagher Brian M. Jr. (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns:
| Granted 40,000 options to buy
@ $11.36, valued at
$454.4k
|
|
10/08/2021 |
4
| Gallagher Brian M. Jr. (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns:
| Granted 40,000 options to buy
@ $11.36, valued at
$454.4k
|
|
08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/05/2018 |
4
| Gallagher Brian M. Jr. (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Converted 1,674,016 shares
@ $0 Converted 1,300,116 shares
@ $0 Converted 454,550 shares
@ $0 Bought 269,230 shares
@ $13, valued at
$3.5M
Converted 9,300,000 preferred shares
@ $0 Converted 7,222,797 preferred shares
@ $0 Converted 2,525,253 preferred shares
@ $0 |
|
06/27/2018 |
3
| Gallagher Brian M. Jr. (Director) has filed a Form 3 on Translate Bio, Inc. |
07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/28/2017 |
3
| Gallagher Brian M. Jr. (Director) has filed a Form 3 on AILERON THERAPEUTICS INC |
|
|